Perigon Wealth Management LLC Invests $968,000 in Danaher Corporation $DHR

Perigon Wealth Management LLC acquired a new stake in shares of Danaher Corporation (NYSE:DHR) during the second quarter, according to its most recent filing with the Securities & Exchange Commission. The firm acquired 5,081 shares of the conglomerate’s stock, valued at approximately $968,000.

Other institutional investors also recently bought and sold shares of the company. Northwestern Mutual Wealth Management Co. lifted its stake in shares of Danaher by 303.7% during the 4th quarter. Northwestern Mutual Wealth Management Co. now owns 248,020 shares of the conglomerate’s stock worth $56,777,000 after purchasing an additional 186,584 shares during the last quarter. Legal & General Group Plc grew its stake in Danaher by 1.0% in the fourth quarter. Legal & General Group Plc now owns 4,495,287 shares of the conglomerate’s stock valued at $1,029,061,000 after purchasing an additional 43,169 shares during the last quarter. Zurcher Kantonalbank Zurich Cantonalbank raised its holdings in Danaher by 51.5% in the fourth quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 271,734 shares of the conglomerate’s stock worth $62,205,000 after purchasing an additional 92,323 shares in the last quarter. Advisors Capital Management LLC lifted its position in shares of Danaher by 14.0% during the fourth quarter. Advisors Capital Management LLC now owns 54,845 shares of the conglomerate’s stock valued at $12,555,000 after buying an additional 6,720 shares during the last quarter. Finally, Handelsbanken Fonder AB boosted its holdings in shares of Danaher by 10.9% in the 2nd quarter. Handelsbanken Fonder AB now owns 289,223 shares of the conglomerate’s stock valued at $55,091,000 after buying an additional 28,425 shares in the last quarter. 79.05% of the stock is owned by hedge funds and other institutional investors.

Analyst Ratings Changes

Several research analysts recently commented on the stock. Evercore reiterated an “outperform” rating and set a $230.00 price objective on shares of Danaher in a research note on Monday, July 6th. TD Cowen cut their price target on shares of Danaher from $240.00 to $236.00 and set a “buy” rating on the stock in a report on Wednesday, July 22nd. Piper Sandler assumed coverage on Danaher in a report on Thursday, June 11th. They set a “neutral” rating and a $200.00 price objective for the company. Weiss Ratings upgraded Danaher from a “sell (d+)” rating to a “hold (c-)” rating in a research note on Wednesday, July 15th. Finally, Argus reduced their target price on Danaher from $265.00 to $230.00 and set a “buy” rating on the stock in a research report on Friday, April 24th. One analyst has rated the stock with a Strong Buy rating, nineteen have issued a Buy rating and five have assigned a Hold rating to the company. Based on data from MarketBeat, the stock currently has an average rating of “Moderate Buy” and a consensus price target of $228.91.

Danaher Trading Down 1.5%

NYSE:DHR opened at $199.62 on Wednesday. The company has a market capitalization of $140.33 billion, a P/E ratio of 35.46, a PEG ratio of 2.52 and a beta of 0.78. The company has a current ratio of 1.65, a quick ratio of 1.25 and a debt-to-equity ratio of 0.48. Danaher Corporation has a 12 month low of $160.93 and a 12 month high of $242.80. The firm has a fifty day simple moving average of $193.74 and a 200-day simple moving average of $192.50.

Danaher (NYSE:DHR) last released its earnings results on Monday, July 20th. The conglomerate reported $1.94 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.85 by $0.09. The firm had revenue of $6.26 billion for the quarter, compared to the consensus estimate of $6.12 billion. Danaher had a return on equity of 11.04% and a net margin of 15.95%.The firm’s revenue was up 5.5% on a year-over-year basis. During the same period in the prior year, the firm earned $0.77 EPS. On average, equities research analysts anticipate that Danaher Corporation will post 8.53 earnings per share for the current year.

Danaher Company Profile

Danaher Corporation (NYSE: DHR) is a global science and technology company that designs, manufactures and markets products and services for the life sciences, diagnostics, and environmental and applied markets. The company organizes its operations into business segments focused on Life Sciences, Diagnostics, and Environmental & Applied Solutions, supplying instruments, reagents, software and related services that support research, clinical testing, biopharmaceutical development, and industrial and environmental monitoring.

Products and services in Danaher’s portfolio include analytical and diagnostic instruments, laboratory consumables and reagents, digital and software solutions for workflow and data management, field and industrial monitoring equipment, and service and maintenance programs.